Early trial tests new drug for severe hair loss condition
NCT ID NCT06060977
First seen Feb 11, 2026 · Last updated Apr 19, 2026 · Updated 8 times
Summary
This early-stage study tested the safety and initial effectiveness of an investigational drug called IMG-007 for adults with alopecia areata who had lost at least 50% of their scalp hair. Participants received three intravenous infusions over four weeks and were followed for 20 weeks. The main goal was to see if the treatment was safe and to measure if it helped regrow hair.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA(AA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance Clinical Research of Tampa
Tampa, Florida, 33615, United States
-
Centre de Recherche Saint-Louis
Québec, Quebec, G1W4R4, Canada
-
Dawes Fretzin Clinical Resarch Group, LLC
Indianapolis, Indiana, 47906, United States
-
Dermatology Specialists of Spokane
Spokane, Washington, 99202, United States
-
Great Lakes Research Group Inc.
Bay City, Michigan, 48706, United States
-
Guelph Dermatology Research
Guelph, Ontario, N1L0B7, Canada
-
Innovaderm Research Inc.
Montreal, Canada
-
Lahey Hospital & Medical Center
Burlington, Massachusetts, 01803, United States
-
Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A.
Rogers, Arkansas, 72758, United States
-
Options Research Group
West Lafayette, Indiana, 47906, United States
-
Research Toronto
Toronto, Ontario, M2W2N4, Canada
-
SimcoMed Health Ltd.
Barrie, Ontario, L4M7G1, Canada
-
Skin Cancer and Dermatology Institute
Reno, Nevada, 89509, United States
-
Skin Health
Cobourg, Ontario, K9A0Z4, Canada
-
Skin Search of Rochester, Inc.
Rochester, New York, 14623, United States
-
Stride Clinical Research LLC
Sugar Land, Texas, 77479, United States
-
Torrance Clinical Research Institute Inc.
Lomita, California, 90717, United States
Conditions
Explore the condition pages connected to this study.